Canadian Marijuana Stocks To Watch In 2022 That May See Better Trading
As marijuana stocks continue to trade down is now a time to be concerned. Since mid-February 2021 the entire cannabis sector has been going through a downtrend in trading. Now with this current drop, many have taken advantage by finding the best marijuana stock to buy. However, the way most have been determining whether a cannabis stock is a buy or not is based on the company’s progress. More specifically if a marijuana company is performing well outside of the market.
By showing more progress or profitability it gives more confidence to investors. Still, you always want to learn all you can about each possible cannabis stock to buy. Still what will help bring the sector back up beyond just news on federal reform. For some time now any positive news on federal reform has resonated well for most of the sector. Although what else will help to bring more momentum to the overall sector.
Right now most US-based cannabis stocks have seen gains from the short volatile swings in trading. It’s been a good amount of time since the bulk of Canadian marijuana stocks has picked up momentum. Although some have seen some better days of trading. As of now, there is a lot of speculation of what will take place for the future of marijuana stock investing. Currently many are remaining optimistic as a new year of trading and investing is soon to take place.
Marijuana Stock Investors Are Getting Ready For 2022
Nevertheless, a good amount investors are actively buying the dips and waiting for better upward movement. Which many feel will happen once the eventual end of cannabis prohibition is made law. The cannabis industry in its entirety is still thriving on a major scale. This continued success is attracting new people who want to invest in legal marijuana. So with this now is as good of a time as any to find the right marijuana stocks to watch in 2022. The pot stocks below are just a few to keep on the radar as possible options to invest in.
Top Marijuana Stocks For Your 2022 Watchlist
- OrganiGram Holdings Inc. (NASDAQ:OGI)
- Cronos Group Inc. (NASDAQ:CRON)
OrganiGram Holdings Inc.
OrganiGram Holdings Inc. through its subsidiaries produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers. As well as cannabis oils, and vaporizers for civilian patients and veterans; adult-use recreational cannabis. Back on November 23rd, the company released its Q4 fiscal 2021 results. The company achieved a 7% share of the market in the recreational cannabis market in Q4. This is up from 5.4% in Q3 2021, positioning Organigram as the #4 licensed producer.
Next OrganiGram saw a 24% growth in gross revenue to $36.2 million in Q4 2021. And from Q3 2021 and 43% from the same prior-year period. Another highlight is the launch of Edison JOLTS, an ingestible extract lozenge that is the #1 SKU 3 in its category. As well they also reached a 36% growth in recreational net revenue to $22.9 million in Q4 2021. Which is from Q3 2021 and 52% from the same prior-year period. And a 22% growth in net revenue to $24.9 million in Q4 2021. These figures are from Q3 2021 and 22% from the same prior-year period.
Words From The Company
“The results in Q4 Fiscal 2021 demonstrate the momentum we have achieved from our efforts to lead innovation and increase efficiencies. In the quarter, we introduced exciting new products that were embraced by consumers and we achieved higher crop yields at a lower cost” said Beena Goldenberg, Chief Executive Officer. “We are particularly pleased with our market share gains in the quarter to become a #4 LP and will build on these successes into Fiscal 2022.”
[Read More] 2 Top Canadian Marijuana Stocks To Watch In 2022
Cronos Group Inc.
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce. As well as retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products. Which are for the medical and adult-use markets.
In the most recent news, Cronos has provided a Bi-weekly MCTO status update. On November 9, 2021, the Company announced that it applied for a management cease trade order (“MCTO”). This was done with the applicable securities regulatory authorities in Canada. Which was on the basis that the company would be unable to file its Quarterly Report on Form 10-Q for the period ended September 30, 2021. The MCTO was issued on November 16, 2021, and restricts all trading in securities of the Company.
[Read More] How To Invest In Marijuana Stocks In 2022
Meaning whether direct or indirect, by the Chief Executive Officer and Chief Financial Officer of the Company. Specifically, until two full business days following the filing of the Required Filings and the MCTO has been revoked. The MCTO does not affect the ability of other shareholders of the Company to trade their securities. The Company confirms that since the date of the Original Announcement: (i) there has been no material change to the information. The Company’s management continues to work diligently to complete the Required Filings.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
